A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

NCT07181681 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Advanced Solid Tumor

Interventions

DRUG: BG-C0902

Sponsor

BeOne Medicines